310 related articles for article (PubMed ID: 3873243)
1. Anti-ulcer effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl) phenyl] propionic acid hydrochloride (TEI-5103).
Hoshina K; Yamazaki N; Takeshita T; Naruchi T
Arzneimittelforschung; 1985; 35(2):493-7. PubMed ID: 3873243
[TBL] [Abstract][Full Text] [Related]
2. Effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl)-phenyl] propionic acid hydrochloride on gastric mucosal blood flow.
Hoshina K; Okada N; Inoue K; Yamamoto M; Saito N; Takeshita T; Naruchi T
Arzneimittelforschung; 1987 Nov; 37(11):1284-9. PubMed ID: 3440037
[TBL] [Abstract][Full Text] [Related]
3. Effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl)phenyl] propionic acid hydrochloride on gastric mucosa directly from the lumen.
Hoshina K; Tanabe H; Yamazaki N; Yamamoto M; Ohba T; Takeshita T; Naruchi T
Arzneimittelforschung; 1987 Nov; 37(11):1289-95. PubMed ID: 3440038
[TBL] [Abstract][Full Text] [Related]
4. Antiulcer effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl] carbamoyl]methyl]-amino-N-methylbenzamide in experimental gastric and duodenal ulcers.
Asano M; Kurebayashi Y; Ryokawa Y; Hashizume T; Akashi A
Arzneimittelforschung; 1990 Mar; 40(3):276-81. PubMed ID: 2346535
[TBL] [Abstract][Full Text] [Related]
5. Effects of the novel anti-ulcer agent 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine on experimental ulcers and gastric secretion in rats.
Tanaka T; Bickel M; Herling AW; Sakurai M; Goto M; Hayashi S
Arzneimittelforschung; 1989 Jun; 39(6):689-94. PubMed ID: 2775336
[TBL] [Abstract][Full Text] [Related]
6. Effects of 5-acetylspiro[benzofuran-2(3H),1'-cyclopropan]-3-one, a new anti-ulcer agent, on experimental acute and chronic ulcers.
Inatomi N; Hirata T; Inada I; Satoh H; Sino A; Maki Y
Arzneimittelforschung; 1985; 35(10):1553-9. PubMed ID: 4074415
[TBL] [Abstract][Full Text] [Related]
7. Anti-ulcer effect of 1,6-dihydro-2-[2-(2-methylpropoxy) anilino]-6-oxo-5-pyrimidinecarboxylic acid on experimental gastric ulcers in rats.
Ishizuka Y; Kamisaki T; Matsuda M; Shimazaki I; Kawashima M; Yaginuma H; Terashima K; Sato M
Arzneimittelforschung; 1994 Apr; 44(4):509-13. PubMed ID: 8011005
[TBL] [Abstract][Full Text] [Related]
8. Effect of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric ulcers and gastric secretion in experimental animals.
Ueda F; Aratani S; Mimura K; Kimura K; Nomura A; Enomoto H
Arzneimittelforschung; 1984; 34(4):474-7. PubMed ID: 6540106
[TBL] [Abstract][Full Text] [Related]
9. Effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl)phenyl]propionic acid hydrochloride on gastric mucosal barrier.
Hoshina K; Yamazaki N; Takeshita T; Naruchi T
Arzneimittelforschung; 1987 Oct; 37(10):1154-8. PubMed ID: 3435587
[TBL] [Abstract][Full Text] [Related]
10. Gastric anti-ulcer and cytoprotective properties of 2-(3,4-dimethoxyphenyl)-5-methyl-thiazolidine-4-one in rat experimental ulcers.
Matsuo Y; Kuwayama H; Itoh H; Seki A; Fukuda S; Kawasaki T; Hotta T; Ohsaka Y; Komatsu K
Arzneimittelforschung; 1986 Aug; 36(8):1236-40. PubMed ID: 3778561
[TBL] [Abstract][Full Text] [Related]
11. Healing effects of heparin on acetic acid-induced gastric ulcers in rats.
Li Y; Mei QB; Cho CH
Chin Med J (Engl); 1998 Jan; 111(1):12-6. PubMed ID: 10322645
[TBL] [Abstract][Full Text] [Related]
12. Effects of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)-acetoxyacetamide hydrochloride (TZU-0460), a histamine H2-receptor antagonist, on gastric acid secretion and ulcer formation.
Tarutani M; Sakuma H; Shiratsuchi K; Mieda M
Arzneimittelforschung; 1985; 35(5):844-8. PubMed ID: 2862875
[TBL] [Abstract][Full Text] [Related]
13. SU-840, a novel synthetic flavonoid derivative of sophoradin, with potent gastroprotective and ulcer healing activity.
Brzozowski T; Konturek SJ; Kwiecien S; Pajdo R; Drozdowicz D; Sliwowski Z; Muramatsu M
J Physiol Pharmacol; 1998 Mar; 49(1):83-98. PubMed ID: 9594413
[TBL] [Abstract][Full Text] [Related]
14. Effects of indomethacin and cold-stress on gastric acid secretion and ulceration. The effects of anti-acid secretory agents in rats.
Arai I; Hirose H; Usuki C; Muramatsu M; Aihara H
Res Commun Chem Pathol Pharmacol; 1987 Sep; 57(3):313-27. PubMed ID: 3671883
[TBL] [Abstract][Full Text] [Related]
15. Effect of peroxisome proliferator-activated receptor-alpha agonist (bezafibrate) on gastric secretion and gastric cytoprotection in rats.
Pathak R; Asad M; Hrishikeshavan HJ; Prasad S
Fundam Clin Pharmacol; 2007 Jun; 21(3):291-6. PubMed ID: 17521298
[TBL] [Abstract][Full Text] [Related]
16. Effect of centrally administered oxytocin on gastric and duodenal ulcers in rats.
Asad M; Shewade DG; Koumaravelou K; Abraham BK; Vasu S; Ramaswamy S
Acta Pharmacol Sin; 2001 Jun; 22(6):488-92. PubMed ID: 11747752
[TBL] [Abstract][Full Text] [Related]
17. Effect of 1,6-dihydro-2-[2-(2-methylpropoxy)anilino]-6-oxo-5-pyrimidinecarboxylic acid on gastric mucosal defensive factors and gastric secretion in rats.
Ishizuka Y; Kamisaki T; Okamoto N; Matsuda M; Shimazaki I; Kimura I; Kamiya A; Kataoka M; Kawashima M; Terashima K
Arzneimittelforschung; 1994 May; 44(5):620-6. PubMed ID: 8024635
[TBL] [Abstract][Full Text] [Related]
18. Gastric antisecretory and antiulcer effects of WHR1582A, a compound exerting alpha-2 adrenoceptor agonist activity.
DiJoseph JF; Eash JR; Mir GN
J Pharmacol Exp Ther; 1987 Apr; 241(1):97-102. PubMed ID: 2883297
[TBL] [Abstract][Full Text] [Related]
19. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
[TBL] [Abstract][Full Text] [Related]
20. Effect and mechanism of sucralfate on healing of acetic acid-induced gastric ulcers in rats.
Ogihara Y; Okabe S
J Physiol Pharmacol; 1993 Jun; 44(2):109-18. PubMed ID: 8358048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
